In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Harvoni Drug Master File in Korea (Harvoni KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Harvoni. The MFDS reviews the Harvoni KDMF as part of the drug registration process and uses the information provided in the Harvoni KDMF to evaluate the safety and efficacy of the drug.
After submitting a Harvoni KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Harvoni API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Harvoni suppliers with KDMF on PharmaCompass.